Pharmacy and population health
Population-based studies of treatment use
This area of research focuses on how treatments are used in the general population. It looks at the determinants, benefits, risks, and economic implications of treatment use, and considers ways to optimize it. Among other things, research draws on disciplines like pharmacoeconomics and pharmacoepidemiology and considers matters like professional practice and healthcare system organization.
Research topics
Epidemiology and pharmacoepidemiology study the benefits, risks, and effects of medications used by the general population. In particular, they draw on data from clinical trials and observational studies to examine the results of drug treatments.
Research in this area covers:
- Detection and pharmacovigilance (assessment of adverse effects)
- Risk-benefit analysis
- Patterns of medication use
- Pharmacoeconomics (the cost-effectiveness of treatments)
Our researchers
Michel Dorval, Jean-Philippe Drouin-Chartier, Line Guénette, Danielle Laurin, Sophie Lauzier, Jacinthe Leclerc, Caroline Sirois, Arsène Zongo.
Population health research into treatment compliance aims to improve public health and wellness by developing effective and efficient strategies like information and outreach campaigns to promote optimal medication use.
Our researchers
Michel Dorval, Jean-Philippe Drouin-Chartier, Line Guénette, Danielle Laurin, Sophie Lauzier, Jacinthe Leclerc, Caroline Sirois, Arsène Zongo.
This research focuses on the healthcare system, its structure, its management, and its administrative policies.
Our researchers
Michel Dorval, Line Guénette, Sophie Lauzier.
Featured research projects at the Faculty
Discover how our researchers are bringing our major research areas to life through innovative and impactful projects.
PRIME-OncoTransition for Breast Cancer: A smooth hospital-community transition for people aged 65+ undergoing post-treatment preventive medication
Researcher: Sophie Lauzier
This project aims to generate robust, transferable evidence on adjuvant endocrine therapy (AET) management for women aged 65 and older with breast cancer, and inform national and transnational policies in Europe, Switzerland, and Canada. By centering around the voices of women aged 65+, PRIME fosters equity, integration, and person-partnership in survivorship care, offering a solution to meet patient needs.
Assessing the protective effect of dutasteride on Parkinson’s disease: a real-world study following preclinical assessment
Researcher: Arsène Zongo
This project involves analyzing medication dispensing and health service utilization data from Ontario, Alberta, and Québec to compare the incidence and progression of Parkinson’s disease in two groups of people: one taking dutasteride and one taking tamsulosin.
The expected results will provide essential data to pave the way for future clinical trials and could help accelerate the availability of a new treatment for Parkinson’s disease.
Using psilocybin to alleviate existential distress at the end of life: feasibility, acceptability, and access
Researcher: Michel Dorval
As well as providing decision-makers with reports and recommendations, this project is working with the healthcare community to develop a community resource to inform and support patients considering psilocybin-assisted therapy to alleviate existential distress.
